nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Eosinophilia—Procarbazine—brain cancer	0.00739	0.00739	CcSEcCtD
Perflutren—Leukopenia—Lomustine—brain cancer	0.00734	0.00734	CcSEcCtD
Perflutren—Musculoskeletal pain—Temozolomide—brain cancer	0.00728	0.00728	CcSEcCtD
Perflutren—Sweating increased—Procarbazine—brain cancer	0.00728	0.00728	CcSEcCtD
Perflutren—Rigors—Etoposide—brain cancer	0.00705	0.00705	CcSEcCtD
Perflutren—Influenza like illness—Temozolomide—brain cancer	0.00699	0.00699	CcSEcCtD
Perflutren—Coma—Carmustine—brain cancer	0.00681	0.00681	CcSEcCtD
Perflutren—Pain—Carboplatin—brain cancer	0.00654	0.00654	CcSEcCtD
Perflutren—Neuropathy peripheral—Procarbazine—brain cancer	0.00653	0.00653	CcSEcCtD
Perflutren—Abnormal vision—Carmustine—brain cancer	0.0065	0.0065	CcSEcCtD
Perflutren—Face oedema—Hydroxyurea—brain cancer	0.00646	0.00646	CcSEcCtD
Perflutren—Abnormal vision—Temozolomide—brain cancer	0.00628	0.00628	CcSEcCtD
Perflutren—Swelling—Carmustine—brain cancer	0.00613	0.00613	CcSEcCtD
Perflutren—Body temperature increased—Carboplatin—brain cancer	0.00604	0.00604	CcSEcCtD
Perflutren—Haemoglobin—Procarbazine—brain cancer	0.00601	0.00601	CcSEcCtD
Perflutren—Haemorrhage—Procarbazine—brain cancer	0.00598	0.00598	CcSEcCtD
Perflutren—Hot flush—Temozolomide—brain cancer	0.00559	0.00559	CcSEcCtD
Perflutren—Flushing—Procarbazine—brain cancer	0.00555	0.00555	CcSEcCtD
Perflutren—Menopausal symptoms—Temozolomide—brain cancer	0.00554	0.00554	CcSEcCtD
Perflutren—Chills—Procarbazine—brain cancer	0.00536	0.00536	CcSEcCtD
Perflutren—Arrhythmia—Procarbazine—brain cancer	0.00534	0.00534	CcSEcCtD
Perflutren—Body temperature increased—Lomustine—brain cancer	0.00529	0.00529	CcSEcCtD
Perflutren—Face oedema—Carmustine—brain cancer	0.00522	0.00522	CcSEcCtD
Perflutren—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00505	0.00505	CcSEcCtD
Perflutren—Face oedema—Temozolomide—brain cancer	0.00504	0.00504	CcSEcCtD
Perflutren—Tremor—Procarbazine—brain cancer	0.00488	0.00488	CcSEcCtD
Perflutren—Dry skin—Temozolomide—brain cancer	0.00479	0.00479	CcSEcCtD
Perflutren—Swelling—Etoposide—brain cancer	0.00474	0.00474	CcSEcCtD
Perflutren—Syncope—Procarbazine—brain cancer	0.00467	0.00467	CcSEcCtD
Perflutren—Leukopenia—Procarbazine—brain cancer	0.00466	0.00466	CcSEcCtD
Perflutren—Haemoglobin—Hydroxyurea—brain cancer	0.00465	0.00465	CcSEcCtD
Perflutren—Haemorrhage—Hydroxyurea—brain cancer	0.00463	0.00463	CcSEcCtD
Perflutren—Cardiac failure congestive—Etoposide—brain cancer	0.00461	0.00461	CcSEcCtD
Perflutren—Loss of consciousness—Procarbazine—brain cancer	0.00457	0.00457	CcSEcCtD
Perflutren—Cough—Procarbazine—brain cancer	0.00454	0.00454	CcSEcCtD
Perflutren—Convulsion—Procarbazine—brain cancer	0.00451	0.00451	CcSEcCtD
Perflutren—Hypertension—Procarbazine—brain cancer	0.00449	0.00449	CcSEcCtD
Perflutren—Arthralgia—Procarbazine—brain cancer	0.00443	0.00443	CcSEcCtD
Perflutren—Myalgia—Procarbazine—brain cancer	0.00443	0.00443	CcSEcCtD
Perflutren—Sweating increased—Temozolomide—brain cancer	0.0044	0.0044	CcSEcCtD
Perflutren—Dry mouth—Procarbazine—brain cancer	0.00433	0.00433	CcSEcCtD
Perflutren—Anaphylactoid reaction—Etoposide—brain cancer	0.00432	0.00432	CcSEcCtD
Perflutren—Vomiting—Lomustine—brain cancer	0.00425	0.00425	CcSEcCtD
Perflutren—Oedema—Procarbazine—brain cancer	0.00425	0.00425	CcSEcCtD
Perflutren—Angiopathy—Hydroxyurea—brain cancer	0.0042	0.0042	CcSEcCtD
Perflutren—Shock—Procarbazine—brain cancer	0.00418	0.00418	CcSEcCtD
Perflutren—Chills—Hydroxyurea—brain cancer	0.00415	0.00415	CcSEcCtD
Perflutren—Tachycardia—Procarbazine—brain cancer	0.00415	0.00415	CcSEcCtD
Perflutren—Hyperhidrosis—Procarbazine—brain cancer	0.00411	0.00411	CcSEcCtD
Perflutren—Neuropathy peripheral—Carmustine—brain cancer	0.00408	0.00408	CcSEcCtD
Perflutren—Erythema—Hydroxyurea—brain cancer	0.00403	0.00403	CcSEcCtD
Perflutren—Cardiac arrest—Etoposide—brain cancer	0.00398	0.00398	CcSEcCtD
Perflutren—Nausea—Lomustine—brain cancer	0.00397	0.00397	CcSEcCtD
Perflutren—Hypotension—Procarbazine—brain cancer	0.00397	0.00397	CcSEcCtD
Perflutren—Neuropathy peripheral—Temozolomide—brain cancer	0.00395	0.00395	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00387	0.00387	CcSEcCtD
Perflutren—Paraesthesia—Procarbazine—brain cancer	0.00381	0.00381	CcSEcCtD
Perflutren—Cramp muscle—Etoposide—brain cancer	0.00376	0.00376	CcSEcCtD
Perflutren—Haemoglobin—Carmustine—brain cancer	0.00376	0.00376	CcSEcCtD
Perflutren—Haemorrhage—Carmustine—brain cancer	0.00374	0.00374	CcSEcCtD
Perflutren—Ill-defined disorder—Hydroxyurea—brain cancer	0.00374	0.00374	CcSEcCtD
Perflutren—Hypoaesthesia—Carmustine—brain cancer	0.00372	0.00372	CcSEcCtD
Perflutren—Connective tissue disorder—Carmustine—brain cancer	0.00368	0.00368	CcSEcCtD
Perflutren—Fatigue—Procarbazine—brain cancer	0.00366	0.00366	CcSEcCtD
Perflutren—Haemoglobin—Temozolomide—brain cancer	0.00363	0.00363	CcSEcCtD
Perflutren—Malaise—Hydroxyurea—brain cancer	0.00363	0.00363	CcSEcCtD
Perflutren—Pain—Procarbazine—brain cancer	0.00363	0.00363	CcSEcCtD
Perflutren—Haemorrhage—Temozolomide—brain cancer	0.00361	0.00361	CcSEcCtD
Perflutren—Leukopenia—Hydroxyurea—brain cancer	0.00361	0.00361	CcSEcCtD
Perflutren—Visual impairment—Carmustine—brain cancer	0.0036	0.0036	CcSEcCtD
Perflutren—Hypoaesthesia—Temozolomide—brain cancer	0.0036	0.0036	CcSEcCtD
Perflutren—Pharyngitis—Temozolomide—brain cancer	0.00359	0.00359	CcSEcCtD
Perflutren—Bronchospasm—Etoposide—brain cancer	0.00355	0.00355	CcSEcCtD
Perflutren—Connective tissue disorder—Temozolomide—brain cancer	0.00355	0.00355	CcSEcCtD
Perflutren—Sweating increased—Etoposide—brain cancer	0.00352	0.00352	CcSEcCtD
Perflutren—Feeling abnormal—Procarbazine—brain cancer	0.0035	0.0035	CcSEcCtD
Perflutren—Eye disorder—Carmustine—brain cancer	0.0035	0.0035	CcSEcCtD
Perflutren—Convulsion—Hydroxyurea—brain cancer	0.00349	0.00349	CcSEcCtD
Perflutren—Visual impairment—Temozolomide—brain cancer	0.00348	0.00348	CcSEcCtD
Perflutren—Gastrointestinal pain—Procarbazine—brain cancer	0.00347	0.00347	CcSEcCtD
Perflutren—Flushing—Carmustine—brain cancer	0.00347	0.00347	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00341	0.00341	CcSEcCtD
Perflutren—Discomfort—Hydroxyurea—brain cancer	0.00339	0.00339	CcSEcCtD
Perflutren—Eye disorder—Temozolomide—brain cancer	0.00338	0.00338	CcSEcCtD
Perflutren—Urticaria—Procarbazine—brain cancer	0.00337	0.00337	CcSEcCtD
Perflutren—Tinnitus—Temozolomide—brain cancer	0.00337	0.00337	CcSEcCtD
Perflutren—Abdominal pain—Procarbazine—brain cancer	0.00336	0.00336	CcSEcCtD
Perflutren—Body temperature increased—Procarbazine—brain cancer	0.00336	0.00336	CcSEcCtD
Perflutren—Cardiac disorder—Temozolomide—brain cancer	0.00335	0.00335	CcSEcCtD
Perflutren—Flushing—Temozolomide—brain cancer	0.00335	0.00335	CcSEcCtD
Perflutren—Arrhythmia—Carmustine—brain cancer	0.00334	0.00334	CcSEcCtD
Perflutren—Oedema—Hydroxyurea—brain cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Angiopathy—Temozolomide—brain cancer	0.00328	0.00328	CcSEcCtD
Perflutren—Immune system disorder—Temozolomide—brain cancer	0.00326	0.00326	CcSEcCtD
Perflutren—Mediastinal disorder—Temozolomide—brain cancer	0.00326	0.00326	CcSEcCtD
Perflutren—Erythema—Carmustine—brain cancer	0.00326	0.00326	CcSEcCtD
Perflutren—Chills—Temozolomide—brain cancer	0.00324	0.00324	CcSEcCtD
Perflutren—Nervous system disorder—Hydroxyurea—brain cancer	0.00322	0.00322	CcSEcCtD
Perflutren—Skin disorder—Hydroxyurea—brain cancer	0.00319	0.00319	CcSEcCtD
Perflutren—Neuropathy peripheral—Etoposide—brain cancer	0.00316	0.00316	CcSEcCtD
Perflutren—Back pain—Carmustine—brain cancer	0.00315	0.00315	CcSEcCtD
Perflutren—Erythema—Temozolomide—brain cancer	0.00315	0.00315	CcSEcCtD
Perflutren—Hypersensitivity—Procarbazine—brain cancer	0.00313	0.00313	CcSEcCtD
Perflutren—Dysgeusia—Temozolomide—brain cancer	0.00308	0.00308	CcSEcCtD
Perflutren—Vision blurred—Carmustine—brain cancer	0.00307	0.00307	CcSEcCtD
Perflutren—Tremor—Carmustine—brain cancer	0.00305	0.00305	CcSEcCtD
Perflutren—Asthenia—Procarbazine—brain cancer	0.00305	0.00305	CcSEcCtD
Perflutren—Back pain—Temozolomide—brain cancer	0.00304	0.00304	CcSEcCtD
Perflutren—Pruritus—Procarbazine—brain cancer	0.003	0.003	CcSEcCtD
Perflutren—Agitation—Carmustine—brain cancer	0.00299	0.00299	CcSEcCtD
Perflutren—Vision blurred—Temozolomide—brain cancer	0.00297	0.00297	CcSEcCtD
Perflutren—Tremor—Temozolomide—brain cancer	0.00295	0.00295	CcSEcCtD
Perflutren—Dyspnoea—Hydroxyurea—brain cancer	0.00293	0.00293	CcSEcCtD
Perflutren—Ill-defined disorder—Temozolomide—brain cancer	0.00292	0.00292	CcSEcCtD
Perflutren—Leukopenia—Carmustine—brain cancer	0.00291	0.00291	CcSEcCtD
Perflutren—Diarrhoea—Procarbazine—brain cancer	0.00291	0.00291	CcSEcCtD
Perflutren—Dyspepsia—Hydroxyurea—brain cancer	0.00289	0.00289	CcSEcCtD
Perflutren—Agitation—Temozolomide—brain cancer	0.00289	0.00289	CcSEcCtD
Perflutren—Hypoaesthesia—Etoposide—brain cancer	0.00288	0.00288	CcSEcCtD
Perflutren—Angioedema—Temozolomide—brain cancer	0.00287	0.00287	CcSEcCtD
Perflutren—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00284	0.00284	CcSEcCtD
Perflutren—Malaise—Temozolomide—brain cancer	0.00284	0.00284	CcSEcCtD
Perflutren—Fatigue—Hydroxyurea—brain cancer	0.00283	0.00283	CcSEcCtD
Perflutren—Vertigo—Temozolomide—brain cancer	0.00283	0.00283	CcSEcCtD
Perflutren—Convulsion—Carmustine—brain cancer	0.00282	0.00282	CcSEcCtD
Perflutren—Leukopenia—Temozolomide—brain cancer	0.00282	0.00282	CcSEcCtD
Perflutren—Hypertension—Carmustine—brain cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Pain—Hydroxyurea—brain cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Dizziness—Procarbazine—brain cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Palpitations—Temozolomide—brain cancer	0.00278	0.00278	CcSEcCtD
Perflutren—Chest pain—Carmustine—brain cancer	0.00277	0.00277	CcSEcCtD
Perflutren—Myalgia—Carmustine—brain cancer	0.00277	0.00277	CcSEcCtD
Perflutren—Cough—Temozolomide—brain cancer	0.00275	0.00275	CcSEcCtD
Perflutren—Convulsion—Temozolomide—brain cancer	0.00273	0.00273	CcSEcCtD
Perflutren—Hypertension—Temozolomide—brain cancer	0.00272	0.00272	CcSEcCtD
Perflutren—Feeling abnormal—Hydroxyurea—brain cancer	0.00271	0.00271	CcSEcCtD
Perflutren—Eye disorder—Etoposide—brain cancer	0.0027	0.0027	CcSEcCtD
Perflutren—Vomiting—Procarbazine—brain cancer	0.0027	0.0027	CcSEcCtD
Perflutren—Flushing—Etoposide—brain cancer	0.00268	0.00268	CcSEcCtD
Perflutren—Cardiac disorder—Etoposide—brain cancer	0.00268	0.00268	CcSEcCtD
Perflutren—Arthralgia—Temozolomide—brain cancer	0.00268	0.00268	CcSEcCtD
Perflutren—Myalgia—Temozolomide—brain cancer	0.00268	0.00268	CcSEcCtD
Perflutren—Rash—Procarbazine—brain cancer	0.00268	0.00268	CcSEcCtD
Perflutren—Dermatitis—Procarbazine—brain cancer	0.00268	0.00268	CcSEcCtD
Perflutren—Headache—Procarbazine—brain cancer	0.00266	0.00266	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00266	0.00266	CcSEcCtD
Perflutren—Oedema—Carmustine—brain cancer	0.00266	0.00266	CcSEcCtD
Perflutren—Discomfort—Temozolomide—brain cancer	0.00265	0.00265	CcSEcCtD
Perflutren—Angiopathy—Etoposide—brain cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Dry mouth—Temozolomide—brain cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Immune system disorder—Etoposide—brain cancer	0.00261	0.00261	CcSEcCtD
Perflutren—Mediastinal disorder—Etoposide—brain cancer	0.00261	0.00261	CcSEcCtD
Perflutren—Body temperature increased—Hydroxyurea—brain cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Chills—Etoposide—brain cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Tachycardia—Carmustine—brain cancer	0.00259	0.00259	CcSEcCtD
Perflutren—Anaphylactic shock—Temozolomide—brain cancer	0.00257	0.00257	CcSEcCtD
Perflutren—Oedema—Temozolomide—brain cancer	0.00257	0.00257	CcSEcCtD
Perflutren—Nausea—Procarbazine—brain cancer	0.00252	0.00252	CcSEcCtD
Perflutren—Nervous system disorder—Temozolomide—brain cancer	0.00252	0.00252	CcSEcCtD
Perflutren—Skin disorder—Temozolomide—brain cancer	0.00249	0.00249	CcSEcCtD
Perflutren—Hypotension—Carmustine—brain cancer	0.00248	0.00248	CcSEcCtD
Perflutren—Hyperhidrosis—Temozolomide—brain cancer	0.00248	0.00248	CcSEcCtD
Perflutren—Dysgeusia—Etoposide—brain cancer	0.00247	0.00247	CcSEcCtD
Perflutren—Back pain—Etoposide—brain cancer	0.00244	0.00244	CcSEcCtD
Perflutren—Hypersensitivity—Hydroxyurea—brain cancer	0.00242	0.00242	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Carmustine—brain cancer	0.00242	0.00242	CcSEcCtD
Perflutren—Muscle spasms—Etoposide—brain cancer	0.00242	0.00242	CcSEcCtD
Perflutren—Paraesthesia—Carmustine—brain cancer	0.00239	0.00239	CcSEcCtD
Perflutren—Dyspnoea—Carmustine—brain cancer	0.00237	0.00237	CcSEcCtD
Perflutren—Asthenia—Hydroxyurea—brain cancer	0.00236	0.00236	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00234	0.00234	CcSEcCtD
Perflutren—Ill-defined disorder—Etoposide—brain cancer	0.00234	0.00234	CcSEcCtD
Perflutren—Paraesthesia—Temozolomide—brain cancer	0.00231	0.00231	CcSEcCtD
Perflutren—Gastrointestinal disorder—Carmustine—brain cancer	0.00229	0.00229	CcSEcCtD
Perflutren—Dyspnoea—Temozolomide—brain cancer	0.00229	0.00229	CcSEcCtD
Perflutren—Pain—Carmustine—brain cancer	0.00227	0.00227	CcSEcCtD
Perflutren—Malaise—Etoposide—brain cancer	0.00227	0.00227	CcSEcCtD
Perflutren—Vertigo—Etoposide—brain cancer	0.00226	0.00226	CcSEcCtD
Perflutren—Dyspepsia—Temozolomide—brain cancer	0.00226	0.00226	CcSEcCtD
Perflutren—Leukopenia—Etoposide—brain cancer	0.00225	0.00225	CcSEcCtD
Perflutren—Diarrhoea—Hydroxyurea—brain cancer	0.00225	0.00225	CcSEcCtD
Perflutren—Gastrointestinal disorder—Temozolomide—brain cancer	0.00222	0.00222	CcSEcCtD
Perflutren—Fatigue—Temozolomide—brain cancer	0.00221	0.00221	CcSEcCtD
Perflutren—Loss of consciousness—Etoposide—brain cancer	0.00221	0.00221	CcSEcCtD
Perflutren—Cough—Etoposide—brain cancer	0.0022	0.0022	CcSEcCtD
Perflutren—Pain—Temozolomide—brain cancer	0.0022	0.0022	CcSEcCtD
Perflutren—Feeling abnormal—Carmustine—brain cancer	0.00219	0.00219	CcSEcCtD
Perflutren—Convulsion—Etoposide—brain cancer	0.00218	0.00218	CcSEcCtD
Perflutren—Hypertension—Etoposide—brain cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Dizziness—Hydroxyurea—brain cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Gastrointestinal pain—Carmustine—brain cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Chest pain—Etoposide—brain cancer	0.00214	0.00214	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00213	0.00213	CcSEcCtD
Perflutren—Discomfort—Etoposide—brain cancer	0.00212	0.00212	CcSEcCtD
Perflutren—Feeling abnormal—Temozolomide—brain cancer	0.00212	0.00212	CcSEcCtD
Perflutren—Abdominal pain—Carmustine—brain cancer	0.0021	0.0021	CcSEcCtD
Perflutren—Body temperature increased—Carmustine—brain cancer	0.0021	0.0021	CcSEcCtD
Perflutren—Gastrointestinal pain—Temozolomide—brain cancer	0.0021	0.0021	CcSEcCtD
Perflutren—Vomiting—Hydroxyurea—brain cancer	0.00209	0.00209	CcSEcCtD
Perflutren—Rash—Hydroxyurea—brain cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Dermatitis—Hydroxyurea—brain cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Headache—Hydroxyurea—brain cancer	0.00206	0.00206	CcSEcCtD
Perflutren—Anaphylactic shock—Etoposide—brain cancer	0.00205	0.00205	CcSEcCtD
Perflutren—Urticaria—Temozolomide—brain cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Body temperature increased—Temozolomide—brain cancer	0.00203	0.00203	CcSEcCtD
Perflutren—Abdominal pain—Temozolomide—brain cancer	0.00203	0.00203	CcSEcCtD
Perflutren—Tachycardia—Etoposide—brain cancer	0.00201	0.00201	CcSEcCtD
Perflutren—Skin disorder—Etoposide—brain cancer	0.002	0.002	CcSEcCtD
Perflutren—Hyperhidrosis—Etoposide—brain cancer	0.00199	0.00199	CcSEcCtD
Perflutren—Hypersensitivity—Carmustine—brain cancer	0.00196	0.00196	CcSEcCtD
Perflutren—Nausea—Hydroxyurea—brain cancer	0.00195	0.00195	CcSEcCtD
Perflutren—Hypotension—Etoposide—brain cancer	0.00192	0.00192	CcSEcCtD
Perflutren—Asthenia—Carmustine—brain cancer	0.00191	0.00191	CcSEcCtD
Perflutren—Hypersensitivity—Temozolomide—brain cancer	0.00189	0.00189	CcSEcCtD
Perflutren—Paraesthesia—Etoposide—brain cancer	0.00185	0.00185	CcSEcCtD
Perflutren—Asthenia—Temozolomide—brain cancer	0.00184	0.00184	CcSEcCtD
Perflutren—Dyspnoea—Etoposide—brain cancer	0.00183	0.00183	CcSEcCtD
Perflutren—Diarrhoea—Carmustine—brain cancer	0.00182	0.00182	CcSEcCtD
Perflutren—Pruritus—Temozolomide—brain cancer	0.00182	0.00182	CcSEcCtD
Perflutren—Gastrointestinal disorder—Etoposide—brain cancer	0.00177	0.00177	CcSEcCtD
Perflutren—Fatigue—Etoposide—brain cancer	0.00177	0.00177	CcSEcCtD
Perflutren—Dizziness—Carmustine—brain cancer	0.00176	0.00176	CcSEcCtD
Perflutren—Pain—Etoposide—brain cancer	0.00176	0.00176	CcSEcCtD
Perflutren—Diarrhoea—Temozolomide—brain cancer	0.00176	0.00176	CcSEcCtD
Perflutren—Dizziness—Temozolomide—brain cancer	0.0017	0.0017	CcSEcCtD
Perflutren—Feeling abnormal—Etoposide—brain cancer	0.00169	0.00169	CcSEcCtD
Perflutren—Vomiting—Carmustine—brain cancer	0.00169	0.00169	CcSEcCtD
Perflutren—Gastrointestinal pain—Etoposide—brain cancer	0.00168	0.00168	CcSEcCtD
Perflutren—Rash—Carmustine—brain cancer	0.00168	0.00168	CcSEcCtD
Perflutren—Dermatitis—Carmustine—brain cancer	0.00167	0.00167	CcSEcCtD
Perflutren—Headache—Carmustine—brain cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Vomiting—Temozolomide—brain cancer	0.00163	0.00163	CcSEcCtD
Perflutren—Urticaria—Etoposide—brain cancer	0.00163	0.00163	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—brain cancer	0.00162	0.00162	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—brain cancer	0.00162	0.00162	CcSEcCtD
Perflutren—Rash—Temozolomide—brain cancer	0.00162	0.00162	CcSEcCtD
Perflutren—Dermatitis—Temozolomide—brain cancer	0.00162	0.00162	CcSEcCtD
Perflutren—Headache—Temozolomide—brain cancer	0.00161	0.00161	CcSEcCtD
Perflutren—Nausea—Carmustine—brain cancer	0.00158	0.00158	CcSEcCtD
Perflutren—Nausea—Temozolomide—brain cancer	0.00153	0.00153	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—brain cancer	0.00151	0.00151	CcSEcCtD
Perflutren—Asthenia—Etoposide—brain cancer	0.00147	0.00147	CcSEcCtD
Perflutren—Pruritus—Etoposide—brain cancer	0.00145	0.00145	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—brain cancer	0.00141	0.00141	CcSEcCtD
Perflutren—Dizziness—Etoposide—brain cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Vomiting—Etoposide—brain cancer	0.00131	0.00131	CcSEcCtD
Perflutren—Rash—Etoposide—brain cancer	0.0013	0.0013	CcSEcCtD
Perflutren—Dermatitis—Etoposide—brain cancer	0.00129	0.00129	CcSEcCtD
Perflutren—Headache—Etoposide—brain cancer	0.00129	0.00129	CcSEcCtD
Perflutren—Nausea—Etoposide—brain cancer	0.00122	0.00122	CcSEcCtD
